Trial record 1 of 2 for:    first-hd
Previous Study | Return to List | Next Study

First Time Use of SD-809 in Huntington Disease (First-HD)

This study is currently recruiting participants.
Verified April 2014 by Auspex Pharmaceuticals, Inc.
Sponsor:
Information provided by (Responsible Party):
Auspex Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01795859
First received: February 20, 2013
Last updated: April 16, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)